T2 Biosystems, Inc.·4

Oct 11, 5:00 PM ET

Elsbree David B 4

4 · T2 Biosystems, Inc. · Filed Oct 11, 2023

Insider Transaction Report

Form 4
Period: 2023-09-15
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2023-09-152,3000 total
    Common Stock (2,300 underlying)
  • Exercise/Conversion

    Common Stock

    2023-09-15+2,3007,824 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    200
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]The reporting person disclaims ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  • [F3]On October 11, 2022, the reporting person was granted 2,300 restricted stock units that vested on the earlier of (i) October 11, 2023, and (ii) the date of the next annual meeting of stockholders.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4